XML 77 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 7,425 $ 9,676
Short-term investments 7 774
Accounts receivable (net of allowance for doubtful accounts of $89 in 2020 and $86 in 2019) 8,182 6,778
Inventories (excludes inventories of $1,630 in 2020 and $1,480 in 2019 classified in Other assets - see Note 6) 5,846 5,978
Other current assets 4,714 4,277
Total current assets 26,174 27,483
Investments 555 1,469
Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,706 in 2020 and $17,686 in 2019 15,269 15,053
Goodwill 19,767 19,425
Other Intangibles, Net 16,096 14,196
Other Assets 7,052 6,771
Total Assets 84,913 84,397
Current Liabilities    
Loans payable and current portion of long-term debt 6,361 3,610
Trade accounts payable 3,572 3,738
Accrued and other current liabilities 10,932 12,549
Income taxes payable 1,033 736
Dividends payable 1,585 1,587
Total current liabilities 23,483 22,220
Long-Term Debt 21,637 22,736
Deferred Income Taxes 1,943 1,470
Other Noncurrent Liabilities 11,550 11,970
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019 1,788 1,788
Other paid-in capital 39,697 39,660
Retained earnings 48,272 46,602
Accumulated other comprehensive loss (6,391) (6,193)
Stockholders' equity before deduction for treasury stock 83,366 81,857
Less treasury stock, at cost: 1,053,090,194 shares in 2020 and 1,038,087,496 shares in 2019 57,161 55,950
Total Merck & Co., Inc. stockholders’ equity 26,205 25,907
Noncontrolling Interests 95 94
Total equity 26,300 26,001
Liabilities and Equity $ 84,913 $ 84,397